Valproic Acid

glycogen synthase kinase 3 beta ; Mus musculus







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30674062 Effects of HIV-1 Tat on oligodendrocyte viability are mediated by CaMKIIβ-GSK3β interactions. 2019 Apr 1
2 27639185 Valproic Acid and Lithium Meditate Anti-Inflammatory Effects by Differentially Modulating Dendritic Cell Differentiation and Function. 2017 May 2
3 28678521 Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury. 2017 Nov 1
4 29179438 Valproate hampers podocyte acquisition of immune phenotypes via intercepting the GSK3β facilitated NFkB activation. 2017 Oct 24 6
5 26056233 The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. 2015 Jun 29 4
6 26385876 Valproic Acid Modifies Synaptic Structure and Accelerates Neurite Outgrowth Via the Glycogen Synthase Kinase-3β Signaling Pathway in an Alzheimer's Disease Model. 2015 Nov 1
7 26413814 Valproic acid enhances the efficacy of radiation therapy by protecting normal hippocampal neurons and sensitizing malignant glioblastoma cells. 2015 Oct 27 2
8 26459714 Selective disruption of dopamine D2-receptors/beta-arrestin2 signaling by mood stabilizers. 2015 Jun 1
9 23848820 Posttrauma cotreatment with lithium and valproate: reduction of lesion volume, attenuation of blood-brain barrier disruption, and improvement in motor coordination in mice with traumatic brain injury. 2013 Sep 4
10 21998135 Endoplasmic reticulum stress and glycogen synthase kinase-3β activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis. 2012 Jan 2
11 22649795 Inhibition of GSK3 attenuates amphetamine-induced hyperactivity and sensitization in the mouse. 2012 May 16 1
12 21435383 Valproate reduces tau phosphorylation via cyclin-dependent kinase 5 and glycogen synthase kinase 3 signaling pathways. 2011 May 30 2
13 21796107 Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington's disease. 2011 Nov 4
14 20511724 Hyperactivity and enhanced curiosity of mice expressing PKB/SGK-resistant glycogen synthase kinase-3 (GSK-3). 2010 1
15 20816918 Valproate attenuates the development of morphine antinociceptive tolerance. 2010 Nov 19 3
16 19095952 Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis. 2009 Jan 3
17 19328817 Cocaine-induced hyperactivity and sensitization are dependent on GSK3. 2009 Jun 2
18 19508174 Deacetylase inhibitors modulate the myostatin/follistatin axis without improving cachexia in tumor-bearing mice. 2009 Aug 1
19 18322101 Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition. 2008 Mar 5 2
20 16497810 Phosphatidylinositol 3-kinase and glycogen synthase kinase 3 regulate estrogen receptor-mediated transcription in neuronal cells. 2006 Jun 1
21 15691529 Hypoxia activates glycogen synthase kinase-3 in mouse brain in vivo: protection by mood stabilizers and imipramine. 2005 Feb 1 2
22 15170327 Lithium, a common drug for bipolar disorder treatment, regulates amyloid-beta precursor protein processing. 2004 Jun 8 3
23 15579172 Benefit of valproic acid in suppressing disease progression of ALS model mice. 2004 Dec 3